23478-60-6

Usage

Uses

Used in Organic Synthesis:
Anthracene-1,4,5,8,9,10-hexol is used as a reducing agent in organic synthesis for its ability to facilitate chemical reactions, particularly in the reduction of other compounds.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, anthracene-1,4,5,8,9,10-hexol is used as an antioxidant for its capacity to scavenge free radicals, which can be beneficial in the development of treatments for various diseases and conditions where oxidative stress plays a role.
Used in Production of Dyes and Pigments:
Anthracene-1,4,5,8,9,10-hexol is utilized in the production of dyes and pigments due to its chemical structure and properties that lend themselves to coloration applications.
Used in Environmental Applications:
While its use is limited due to toxicity and environmental concerns, anthracene-1,4,5,8,9,10-hexol has potential applications in environmental remediation or as a component in processes that require its specific chemical properties, provided that proper safety and disposal protocols are followed.

Upstream product

• 61604-82-8 1,8-diamino-4,5-dimethoxy-anthraquinone 
• 1533-34-2 1,5-diamino-4,8-dimethoxyanthraquinone 
• 145-49-3 4,8-diamino-1,5-dihydroxyanthraquinone 
• 117-12-4 1,5-dihydroxyanthraquinone 
• 117-10-2 1,8-dihydroxy-9,10-anthracenedione 
• 54514-58-8 anthracene-1,4,5,8,9,10-hexaone 

Downstream Products

• 3179-90-6 5,8-dihydroxy-1,4-bis<<2-hydroxyethyl>amino>-9,10-anthracenedione 
• 81099-45-8 1,4-bis-{[2-(di(2-hydroxyethyl)amino)ethyl]amino}-5,8-dihydroxyanthracene-9,10-dione 
• 134566-65-7 1-<<2-(dimethylamino)ethyl>amino>-4-<<2-<2-(hydroxyethyl)amino>ethyl>amino>-5,8-dihydroxyanthracene-9,10-dione 
• 70476-63-0 1,4-bis{[2-(dimethylamino)ethyl]amino}-5,8-dihydroxyanthracene-9,10-dione 
• 70476-67-4 1,4-bis-{[2-(diethylamino)ethyl]amino)-5,8-dihydroxyanthracene-9,10-dione 
• 132901-54-3 1,4,5,8-tetrakis(dodecyloxy)-11,14-bis(dodecanoyloxy)triptycene 
• 132901-53-2 1,4,5,8-tetrakis(dodecyloxy)-11-hydroxy-14-(dodecanoyloxy)triptycene 
• 132901-58-7 1,4,5,8-tetrakis(dodecyloxy)-11,14-dioxo-11',14'-dihydrotriptycene 
• 132901-59-8 1,4,5,8-tetrakis(dodecyloxy)-11,14-dihydroxytriptycene 
• 146519-49-5 1,4,5,8-tetrakis(dodecyloxy)-9,10-dihydro-9,10-anthracenediol 
• 146519-48-4 1,4,5,8-tetrakis(dodecyloxy)anthraquinone 
• 132901-57-6 1,4,5,8-tetrakis(dodecyloxy)anthracene 
• 81-60-7 1,4,5,8-tetrahydroxy-anthraquinone 

Relevant academic research and scientific papers

Anthraquinone anticancer drugs

A molecule of formula (I); wherein: X is a halogen, or a substituted sulfonate group; m=1-5; n=1-5; R1, R2=H, C1-4 lower alkyl or C1-4 lower alkyl chain having additional functionality; and the amino group ?NR1R2linked to the anthraquinone is primary, secondary or tertiary or is a tertiary group in the N-oxide form having the formula —N(O)R1R2.

Liquid Crystalline Triptycene Derivatives

A route to triptycenes substituted with one, two, five, and six paraffinic chains was developed using the Diels-Alder reaction as the key reaction. 1,4,5,8-Tetrakis(dodecyloxy)-11-hydroxy-14-(dodecanoyloxy)triptycene, 1,4,5,8-tetrakis(dodecyloxy)-11,14-bis(dodecanoyloxy)triptycene, and 1,4,5,8,11,14-hexakis(dodecyloxy)triptycene were obtained in a nine-step procedure starting from diaminoanthrarufin.The five-chain derivative demonstrates original mesomorphic properties.

Use of alpha-di(lower alkoxy) anthraquinones in the synthesis of Alizarin Saphirols

Alpha-dihydroxyanthraquinones used as intermediates in the synthesis of many dyestuffs, such as the Alizarin Saphirols (e.g. Color Constitution No. 63000, 63005, 63010, 63011, 63315 and 63610) can be replaced on an equimolar basis by alpha-di(lower alkoxy)anthraquinones. The alpha-di(lower alkoxy) anthraquinones can be converted in a single step, by treatment with oleum, to the corresponding alpha-dihydroxyanthraquinone-beta-disulfonic acids in almost quantitative yield. The corresponding diamine is obtained by dinitrating followed by reduction of the nitro groups. The known intermediate, leuco 1,4,5,8-tetrahydroxyanthraquinone (see C.I. No. 62500) can be obtained either by reduction of the diamine or by reduction of the dinitro compound. In one embodiment, the alpha-di(lower alkoxy)anthraquinone is obtained from dinitroanthraquinone by treatment thereof with methanol and KOH.